YJH-0425

N/A

Report date: 2023/03/12 17:03:59
NME

Base Information

Drug NameYJH-0425
Drug Alias NameYJH-0425YJH0425
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYoujia (Hangzhou) Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYoujia (Hangzhou) Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A